These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1815454)

  • 1. Growth hormone secretion and the therapeutic effects of human growth hormone: first Japanese results of the Kabi Pharmacia International Growth Study/International Cooperative Growth Study.
    Tanaka T
    Acta Paediatr Scand Suppl; 1991; 379():126-35. PubMed ID: 1815454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi Pharmacia International Growth Study.
    Ranke MB; Guilbaud O
    Acta Paediatr Scand Suppl; 1991; 379():109-15; discussion 116. PubMed ID: 1815451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.
    Ranke MB; Lindberg A; Chatelain P; Wilton P; Cutfield W; Albertsson-Wikland K; Price DA
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1174-83. PubMed ID: 10199749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone neurosecretory dysfunction. A treatable cause of short stature.
    Spiliotis BE; August GP; Hung W; Sonis W; Mendelson W; Bercu BB
    JAMA; 1984 May; 251(17):2223-30. PubMed ID: 6708271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996.
    Price DA; Wilton P; Jönsson P; Albertsson-Wikland K; Chatelain P; Cutfield W; Ranke MB
    Horm Res; 1998; 49(2):91-7. PubMed ID: 9485178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency.
    Reiter EO; Lindberg A; Ranke MB; Price DA; Albertsson-Wikland K; Cowell CT; Bakker B
    Horm Res; 2003; 60(Suppl 1):68-73. PubMed ID: 12955021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone therapy for 3 years: the OZGROW experience.
    Cowell CT; Dietsch S; Greenacre P
    J Paediatr Child Health; 1996 Apr; 32(2):86-93. PubMed ID: 8860379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of the diagnoses in the Kabi Pharmacia International Growth Study.
    Wilton P; Wallström A
    Acta Paediatr Scand Suppl; 1991; 379():93-8; discussion 99. PubMed ID: 1815465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dramatic early postnatal growth failure in children with early onset growth hormone deficiency. The International Board of the Kabi Pharmacia International Growth Study.
    Chatelain P
    Acta Paediatr Scand Suppl; 1991; 379():100-2; discussion 103. PubMed ID: 1815449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of children with idiopathic short stature in the Kabi Pharmacia International Growth Study, and their response to growth hormone treatment. International Board of the Kabi Pharmacia International Growth Study.
    Albertsson-Wikland K
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():75-8. PubMed ID: 8219481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reevaluation of growth hormone deficiency during and after growth hormone (GH) treatment: diagnostic value of GH tests and IGF-I and IGFBP-3 measurements.
    Darendeliler F; Spinu I; Bas F; Bundak R; Isgüven P; Arslanoğlu I; Saka N; Sükür M; Günöz H
    J Pediatr Endocrinol Metab; 2004 Jul; 17(7):1007-12. PubMed ID: 15301049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy?
    Rogol AD; Blethen SL; Sy JP; Veldhuis JD
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):229-37. PubMed ID: 12580940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auxology and response to growth hormone treatment of patients with intrauterine growth retardation or Silver-Russell syndrome: analysis of data from the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study.
    Chatelain PG
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():79-81. PubMed ID: 8219482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first year of treatment with human growth hormone. Analysis of the Kabi International Growth Study.
    Ranke MB; Guilbaud O
    Acta Paediatr Scand Suppl; 1990; 370():122-30. PubMed ID: 2260450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishment and validation of predictive model of short term responses to recombinant human growth hormone treatment in prepubertal short stature children with various growth hormone secretary statuses].
    Su Z; Li YH; Ma HM; Chen HS; DU ML; Gu YF
    Zhonghua Er Ke Za Zhi; 2008 Oct; 46(10):757-62. PubMed ID: 19099881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the growth response in children with various growth disorders treated with growth hormone: analyses of data from the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study.
    Ranke MB; Guilbaud O; Lindberg A; Cole T
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():82-8; discussion 89. PubMed ID: 8219483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reassessment of the optimal growth hormone cut-off level in insulin tolerance testing for growth hormone secretion in patients with childhood-onset growth hormone deficiency during transition to adulthood.
    Bonfig W; Bechtold S; Bachmann S; Putzker S; Fuchs O; Pagel P; Schwarz HP
    J Pediatr Endocrinol Metab; 2008 Nov; 21(11):1049-56. PubMed ID: 19189699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone (GH) response to GH-releasing hormone in children with subnormal integrated concentrations of GH.
    Chalew SA; Armour KM; Levin PA; Thorner MO; Kowarski AA
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1110-5. PubMed ID: 3084533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.